The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...

Me, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $3.5 ...

Nearly the entire board of directors for 23andMe has resigned — a move that apparently was news to its overly-optimistic ...

Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its ...

The independent directors of genetic testing firm 23andMe said on Tuesday they have resigned from the company's board after ...

All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan ...

Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private ... company known for its mail-order DNA-testing kit. Since going public via merger with a special purpose ...

23andMe has amassed a vast trove of DNA from its popular test kits and pioneered using genetic information to determine risks for an array of diseases. It became the first firm, in 2017 ...

Ann Wojcicki, CEO and co-founder of 23andMe, says she is still planning to take the genetic-testing company private despite ...